Emapunil

DB12666InvestigationalSmall molecule

Emapunil has been used in trials studying the basic science and diagnostic of Baseline, Blocking Receptor Binding, and Neurodegenerative Disorders.

Chemical structure of Emapunil
Mechanism
Curator reviewed
Formula / weight
C23H23N5O2 · 401.47 g/mol (avg)
Code names
AC-5216 · XBD-173

Resolves to

Compound
UNIIOG837L732JCAS226954-04-7ChEMBLCHEMBL513922PubChem6433109
Structure
InChIKeyNBMBIEOUVBHEBM-UHFFFAOYSA-NSMILESCCN(CC1=CC=CC=C1)C(=O)CN1C(=O)N(C)C2=CN=C(N=C12)C1=CC=CC=C1
Targets
P30536TSPO

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
10Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Emapunil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In